Episode Details

Shadd Dales and co-host Anthony Varrell, powered by Dutchie, dive into two big stories making waves right now in cannabis and psychedelics.Segment One brings on Noah Hamman, Founder & CEO of AdvisorShares and Managing Director of the AdvisorShares Pure US Cannabis ETF (NYSE Arca: MSOS). For 18 straight trading sessions, MSOS has seen inflows as investors pile into U.S. cannabis equities on the back of rescheduling momentum. Noah explains how he manages those inflows, allocates capital across top operators, and whether building up a cash position makes sense at this stage of the cycle. With cannabis rescheduling chatter intensifying, MSOS (ticker: MSOS) has become one of the most closely watched ETFs in the industry, and Hamman provides insight into what investors should know right now.Segment Two shifts to psychedelics reform. We welcome Shane Pennington, Partner at Blank Rome LLP, and widely regarded as one of the most qualified attorneys in the U.S. on cannabis and psychedelic policy. Shane breaks down the DEA’s decision to advance a petition to reschedule psilocybin, sending it to federal health officials for review. We explore what this move really means, how the process works, and what the implications are for patients, researchers, and the broader therapeutic landscape.0:00:00 IntroNoah Hamman Interview0:02:17 ETF Inflows & Allocation Strategy 0:05:00 Active Management, Liquidity, and Stock Selection 0:07:17 Capacity Challenges, Swaps, and Market Mechanics 0:10:00 ETF Creation/Redemption Process & Market Maker Roles 0:16:08 Shorting, Volume, and ETF Mechanics 0:20:00 Counterparty Risk, Swaps, and Regulatory Oversight 0:22:50 Adding New Components to the ETF 0:24:10 Cash Balance Strategy & Market Impact 0:27:00 Swaps vs. Physical Custody in the ETF 0:29:19 New Investors Post-Rescheduling 0:30:58 ETF Holdings, Balance Sheet Health, and Performance 0:34:00 ETF Inflows, Outflows, and Portfolio Adjustments 0:35:00 Closing Remarks & TransparencyShane Pennington Interview0:35:59 Capital Markets & Cannabis Industry 0:39:01 Presidential Statements & Administrative Process 0:41:00 Psychedelics Policy & DEA Petition 0:44:22 Right to Try Laws & Psilocybin 0:49:10 Rescheduling Process & Timelines 0:55:00 International Psychedelic Companies & VA Partnerships 0:58:16 Human Impact & Policy Change 0:59:38 Podcast Wrap-Up#Cannabis #Investing #ETFs <